HRD Evaluation and Scoring Using OncoScan CNV Assay - A Whole-Genome Microarray Research Solution

Offered By: Labroots via YouTube

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!

Explore homologous recombination deficiency (HRD) evaluation and scoring using the OncoScan CNV Assay in this informative webinar presented by Yann Christinat, PhD and Stephan Bartels, PhD. Learn about this whole-genome microarray research solution and its applications in identifying HRD as a genome-wide biomarker in high-grade ovarian and breast cancers. Discover how PARP inhibitors, a cancer therapeutic class, induce synthetic lethality in tumors with high levels of HRD. Gain valuable insights into the latest advancements in cancer research and potential therapeutic approaches during this 1-hour and 4-minute presentation.

Syllabus

HRD Evaluation and Scoring using OncoScan CNV Assay, a whole-genome microarray research solution

Taught by

Labroots

Related Courses

DNA - from structure to therapy
Jacobs University via iversity Exotic Tumor Database Training
Exotic Species Cancer Research Alliance via Stanford OpenEdx Introduction to Cancer Biology | 肿瘤生物学概论
Tsinghua University via edX Foundations of Understanding and Combating Cancer
Cornell University via World Science U The Data Science of Healthcare, Medicine, and Public Health, with Barton Poulson
LinkedIn Learning